2022
DOI: 10.1007/978-3-030-93337-1_43
|View full text |Cite
|
Sign up to set email alerts
|

Developmental Lead Exposure in Rats Causes Sex-Dependent Changes in Neurobiological and Anxiety-Like Behaviors that Are Improved by Taurine Co-treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 99 publications
0
1
0
Order By: Relevance
“…These differences in the glucose metabolism and muscle enzyme levels in response to taurine in avians suggest that the AMS may need to be reevaluated for its utility as a preclinical model for medical diseases. In recent years, a new body of research is being reported on a broad range of taurine therapeutics and bioenergetics in regulating: oligodendrocytes in neuropathophysiological conditions [25], bioenergetics of the mitochondria in the brain [26], neuroprotection in aged rats [27], how the brain responds to stress and posttraumatic stress disorderlike symptoms in rats [28], recovering frontoexecutive functions and anxiety-like behaviors in lead poisoned rats [29][30][31][32][33][34][35], mitigating against brain excitability and epilepsy [36], to bioenergetic adaptations in skeletal muscle function [37], its ability to influence motor learning following oral supplementation [38], its sex-dependent influences on rat's active avoidance learning processes [39], the way rats respond to resistance training [40] and even in humans in runner adaptations to running trails [41] and improving power during severe and intense exercise [42]. This rich emerging literature will certainly guide the field in next approaches to improving our understanding of the tradeoffs between taurine bioenergetics and therapeutics across different model systems [43,44].…”
Section: Discussionmentioning
confidence: 99%
“…These differences in the glucose metabolism and muscle enzyme levels in response to taurine in avians suggest that the AMS may need to be reevaluated for its utility as a preclinical model for medical diseases. In recent years, a new body of research is being reported on a broad range of taurine therapeutics and bioenergetics in regulating: oligodendrocytes in neuropathophysiological conditions [25], bioenergetics of the mitochondria in the brain [26], neuroprotection in aged rats [27], how the brain responds to stress and posttraumatic stress disorderlike symptoms in rats [28], recovering frontoexecutive functions and anxiety-like behaviors in lead poisoned rats [29][30][31][32][33][34][35], mitigating against brain excitability and epilepsy [36], to bioenergetic adaptations in skeletal muscle function [37], its ability to influence motor learning following oral supplementation [38], its sex-dependent influences on rat's active avoidance learning processes [39], the way rats respond to resistance training [40] and even in humans in runner adaptations to running trails [41] and improving power during severe and intense exercise [42]. This rich emerging literature will certainly guide the field in next approaches to improving our understanding of the tradeoffs between taurine bioenergetics and therapeutics across different model systems [43,44].…”
Section: Discussionmentioning
confidence: 99%